VREX (Varex Imaging) ROCE % : 6.82% (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Varex Imaging ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Varex Imaging's annualized ROCE % for the quarter that ended in Mar. 2025 was 6.82%.

Varex Imaging ROCE % Historical Data

The historical data trend for Varex Imaging's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Varex Imaging ROCE % Chart

Varex Imaging Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

ROCE %

Get a 7-Day Free Trial

-5.23

6.86

8.12

5.53

3.02

Varex Imaging Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
ROCE %	Get a 7-Day Free Trial															3.29	2.75	3.62	3.49	6.82

Varex Imaging ROCE % Calculation

Varex Imaging's annualized ROCE % for the fiscal year that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Sep. 2024 )		(A: Sep. 2023 )		(A: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Sep. 2024 )		(A: Sep. 2023 )		(A: Sep. 2024 )
	=	31.8	/	( ( (1249.6 - 162.8)	+	(1217 - 195.9) )	/ 2 )
	=	31.8	/	( (1086.8	+	1021.1)	/ 2 )
	=	31.8	/	1053.95
	=	3.02 %

Varex Imaging's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	80.8	/	( ( (1332.2 - 150.5)	+	(1357.6 - 168.8) )	/ 2 )
	=	80.8	/	( ( 1181.7	+	1188.8 )	/ 2 )
	=	80.8	/	1185.25
	=	6.82 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2025) EBIT data.

Varex Imaging (NAS:VREX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Varex Imaging ROCE % Related Terms

Thank you for viewing the detailed overview of Varex Imaging's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Varex Imaging Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Varex Imaging Corp (NAS:VREX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

VI4:Germany

Address

1678 S. Pioneer Road, Salt Lake City, UT, USA, 84104

Website

https://www.vareximaging.com

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

Executives

Sunny Sanyal	director, officer: President and CEO	1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Kimberley E. Honeysett	officer: Vice President and Secretary	1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Shubham Maheshwari	officer: Chief Financial Officer	C/O VEECO INSTRUMENTS INC., 1 TERMINAL DRIVE, PLAINVIEW NY 11803
Jay K. Kunkel	director	21557 TELEGRAPH ROAD, SOUTHFIELD MI 48033
Ruediger Naumann-etienne	director
Kathleen Bardwell	director	9 BLACKBERRY DRIVE, HUDSON OH 44236
Kevin Bruce Yankton	officer: Controller & CAO	1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Andrew Hartmann	officer: SVP Sales & Marketing, Medical	1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Timothy E Guertin	director	C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
Brian W Giambattista	officer: SVP and GM, X-ray Detectors	1678 SOUTH PIONEER ROAD, SALT LAKE CITY UT 84104
Erich R Reinhardt	director	VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Mark S. Jonaitis	officer: SVP and GM, X-Ray Sources	1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Clarence R Verhoef	officer: SVP & Chief Financial Officer	VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 95035
Rosebrough Walter M Jr	director	5960 HEISLEY ROAD, MENTOR OH 44060
Carl E. Lacasce	officer: SVP, Sales & Marketing	1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104